Creating software to analyze and visualize genetic data for better understanding of diseases.
Development and Support of the Pathway Tools Software
This study is working on a special software that helps scientists better understand how germs like tuberculosis work, so they can find new ways to fight these diseases.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-10831011 on NIH RePORTER |
What this research studies
This research focuses on developing the Pathway Tools software, which serves as a comprehensive database for storing and analyzing genetic and biochemical information about various organisms. By enabling scientists to construct and query organism-specific databases, the software facilitates the visualization and analysis of complex biological data, including genes, proteins, and metabolic pathways. The project aims to enhance our understanding of disease-causing bacteria, such as Mycobacterium tuberculosis, by developing new algorithms that can infer critical metabolic interactions and support drug design efforts.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by bacterial infections, particularly those caused by Mycobacterium tuberculosis.
Not a fit: Patients with non-bacterial diseases or those not affected by infectious diseases may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved drug design and treatment strategies for diseases caused by bacteria.
How similar studies have performed: Previous research has shown success in using computational models for drug design and understanding metabolic networks, indicating that this approach has potential.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Karp, Peter D — Sri International
- Study coordinator: Karp, Peter D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.